Leaflet UROGRAFIN 76% solution for injection
Indicated for: diagnostic imaging contrast enhancement
Route of administration: injectable
Substance: sodium amidotryzoate (contrast agent)
ATC: V08AA01 (Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, high osmolar x-ray contrast media)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
This medicine may affect the kidneys.
Sodium amidotrizoate is a contrast agent used in medical imaging, particularly in radiography and computed tomography (CT). It helps highlight internal body structures such as blood vessels, kidneys, and the urinary tract.
The substance is administered intravenously or orally, depending on the type of investigation. It is effective in diagnosing various conditions, including tumors, obstructions, or vascular abnormalities.
Side effects may include nausea, a warm sensation, or allergic reactions. In rare cases, severe reactions such as anaphylactic shock may occur. It is important to inform your doctor about any allergies or pre-existing conditions.
The use of Sodium amidotrizoate must be supervised by a specialist, and the patient should follow all instructions given before and after the procedure.
General data about UROGRAFIN 76%
- Substance: sodium amidotryzoate
- Date of last drug list: 01-07-2013
- Commercial code: W53400001
- Concentration: 76%
- Pharmaceutical form: solution for injection
- Quantity: 10
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for sodium amidotryzoate
Concentrations available for sodium amidotryzoate
- 75%
- 76%